[Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].
Atadzhanov
M A
MA
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000378:metabolism; D051381:Rats
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Parkinsonism i 1-metil-4-fenil-1,2,3,6-tetragidropiridin (obzor).